BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to LoVo cell line is 42
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCB1 | 40 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting | NA | 0.48 | 0.0604 | 28627611 |
| ABCB1 | 40 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.0604 | 29956726 |
| CD24 | 1645 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.456 | 29956726 |
| CD24 | 1645 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | qRT-PCR | NA | 0.48 | 0.456 | 30284085 |
| CD24 | 1645 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | RT-PCR | NA | 0.48 | 0.456 | 30552676 |
| CD24 | 1645 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by FACs | NA | 0.48 | 0.456 | 35242031 |
| CD24 | 1645 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA and MACs | NA | 0.48 | 0.456 | 24696849 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting | NA | 0.48 | 1 | 28627611 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 1 | 29956726 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SP assay followed by FACs and IF staining | NA | 0.48 | 1 | 35326523 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | RT-PCR | NA | 0.48 | 1 | 30552676 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by FACs | NA | 0.48 | 1 | 35242031 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs | NA | 0.48 | 1 | 32729895 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs and SFA | NA | 0.48 | 1 | 24970802 |
| CD44 | 1681 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA and MACs | NA | 0.48 | 1 | 24696849 |
| EPCAM | 11529 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.211 | 29956726 |
| EPCAM | 11529 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | RT-PCR | NA | 0.48 | 0.211 | 30552676 |
| EPCAM | 11529 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs and SFA | NA | 0.48 | 0.211 | 24970802 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting | NA | 0.48 | 0.7582 | 28627611 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.7582 | 29956726 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs followed by SP assay and RT-PCR | NA | 0.48 | 0.7582 | 17932721 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | Western Blotting | NA | 0.48 | 0.7582 | 19621338 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | qRT-PCR | NA | 0.48 | 0.7582 | 30284085 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | RT-PCR | NA | 0.48 | 0.7582 | 30552676 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by FACs | NA | 0.48 | 0.7582 | 35242031 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs | NA | 0.48 | 0.7582 | 20711432 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs | NA | 0.48 | 0.7582 | 31393941 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs and Tumorigenicity assay followed by SP assay | NA | 0.48 | 0.7582 | 21826669 |
| PROM1 | 9454 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs followed by Tumorigenicity assay | NA | 0.48 | 0.7582 | 21601882 |
| ALDH1A1 | 402 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | Western Blotting | NA | 0.28 | 0.684 | 29235568 |
| ALDH1A1 | 402 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | qRT-PCR | NA | 0.28 | 0.684 | 30284085 |
| ALDH1A1 | 402 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | RT-PCR | NA | 0.28 | 0.684 | 30552676 |
| ALDH1A1 | 402 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | FACs | NA | 0.28 | 0.684 | 21701559 |
| ALDH1A3 | 409 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | Western Blotting | NA | 0.28 | 0.0201 | 29235568 |
| NANOG | 20857 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by Western Blotting and Tumorigenicity assay | NA | 0.28 | 0.5461 | 33109220 |
| NANOG | 20857 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | qRT-PCR | NA | 0.28 | 0.5461 | 30284085 |
| POU5F1 | 9221 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by Western Blotting and Tumorigenicity assay | NA | 0.28 | 0.6448 | 33109220 |
| POU5F1 | 9221 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | qRT-PCR | NA | 0.28 | 0.6448 | 30284085 |
| SOX2 | 11195 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by Western Blotting and Tumorigenicity assay | NA | 0.28 | 0.5695 | 33109220 |
| ALCAM | 400 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | Irinotecan (CPT?11) | RT-PCR | NA | 0.2 | 0.0583 | 30552676 |
| MIR195 | 31566 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by qRT-PCR | Down | 0.2 | 0.0032 | 33109220 |
| MIR497 | 32088 | LTM | Dukes Type C Colon Cancer | Adenocarcinoma | LoVo | NA | SFA followed by qRT-PCR | Down | 0.2 | 0.0053 | 33109220 |